Search / Trial NCT07130006

Preoperative Use of Peripheral Nerve Blocks in Elderly Patients With Hip Fractures
Launched by UNIVERSITY HOSPITAL OF SPLIT · Aug 11, 2025

Trial Information

Current as of August 30, 2025

Not yet recruiting

Keywords

Elderly Ultrasound Guided Peripheral Nerve Blocks Intravenous Fentanyl Spinal Anaesthesia Eq 5 D 5 L Visual Analog Scale Pain At Rest Dynamic Pain Hip Fracture Surgery

ClinConnect Summary

This clinical trial is studying different types of nerve blocks—special injections that help control pain—in older adults who have broken their hip. The main goal is to find out which nerve block works best to reduce pain before surgery, helps patients get into position more comfortably for spinal anesthesia, lowers the need for other pain medicines, and lasts long enough to help with recovery without slowing down physical therapy. Researchers will also look closely at any medical problems that might happen during the hospital stay after these nerve blocks, spinal anesthesia, and surgery.

The trial is open to men and women aged 60 and older who have a hip fracture caused by a simple fall or similar injury and are scheduled for surgery. It does not include people with multiple serious injuries, severe memory problems, certain kidney issues, or allergies to some common medicines used during the procedure. Participants will be carefully examined before surgery and closely watched afterward until they leave the hospital. Those in the study will either receive one of the nerve blocks or a usual pain medicine called fentanyl before surgery, allowing doctors to compare which approach works best and is safest.

Gender

ALL

Eligibility criteria

Inclusion Criteria:
• both sexes
• 60 years old and older
• diagnosed with a hip fracture resulting from low-energy trauma
• scheduled surgery.
Exclusion Criteria:
• polytraumatized patients
• dementia and acute psychosis patients
• patients for whom spinal anesthesia is contraindicated
• patients with severe renal failure
• patients for whom intravenous administration of tranexamic acid is contraindicated
• patients with proven allergy and contraindications to dexamethasone, non-steroidal anti-rheumatic drugs, opioid analgesics, magnesium sulfate.

About University Hospital Of Split

The University Hospital of Split, a leading medical institution in Croatia, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent academic hospital affiliated with the University of Split, it combines cutting-edge medical practices with rigorous scientific inquiry. The institution specializes in a wide range of medical fields, fostering collaborations among healthcare professionals, researchers, and educators. With a commitment to improving patient outcomes and contributing to the global medical community, the University Hospital of Split plays a pivotal role in the development of new therapies and treatment protocols through its robust clinical trial programs.

Locations

Split, , Croatia

Patients applied

0 patients applied

Trial Officials

Ana Saric Jadrijev, MD

Principal Investigator